C. Yallampalli et al., INFLUENCE OF THE ANTIANDROGEN HYDROXYFLUTAMIDE ON IN-VITRO DEVELOPMENT OF MOUSE EMBRYOS, Journal of Reproduction and Fertility, 99(2), 1993, pp. 467-470
Hydroxyflutamide is a potent nonsteroidal anti-androgenic drug extensi
vely used in laboratory investigations. Our present studies were aimed
at determining whether this antiandrogen modulates development of emb
ryos in vitro. One-cell and two-cell mouse embryos were collected by f
lushing the oviducts and cultured in defined culture media in the pres
ence or absence of various doses of hydroxyflutamide. The development
of embryos from one-cell and two-cell to blastocyst stage was assessed
. Hydroxyflutamide caused a dose-dependent (0-100 mu g ml(-1)) inhibit
ion of development of both one-cell and two-cell embryos; 100% inhibit
ion was observed at 20 mu g ml(-1). The adverse effects of hydroxyflut
amide on two-cell embryo development were completely reversed by testo
sterone in a dose-dependent manner, but not by oestradiol and progeste
rone. These results indicate that the antiandrogen hydroxyflutamide in
hibits early embryo development suggesting that it may be useful durin
g the preimplantation period for preventing conception.